March 24, 2017
The Japan Pharmaceutical Manufacturers Association (JPMA) said on March 23 that it has reprimanded Celgene over a violation of side effect reporting requirements, which triggered the health ministry’s business improvement order earlier this month. At the day’s press conference, the...read more